Week 283 Review - Combined portfolios back in the black and so is Optibiotix

What a week!

Loads of massive risers, one of which was OPTI:Optibiotix and so the deficit between cost and value was completely wiped out and the combined portfolios went into profit for the first time since April 2019.

The difference between cost and value improved by £11,442 and the portfolios are now £3,712 in profit. The total portfolio value plus cash is a record £133,271.

There was only one share that let the side down, with my new gold miner HUM:Hummingbird Resources dropping 6% to go 8% down altogether. I hope I don't regret this purchase, but it was only a £500 investment.

CMCL:Caledonia Mining have started to rise, and climbed 5% this week. They are still 15% down but I'm hoping that will be recovered as we near the dividend date.

BLU:Blue Star Capital climbed 10% probably on the coat-tails of the cryptocurrency rises. They are still 67% down so a long way to go yet.

OPTI:Optibiotix climbed 7p which is 11% and has gone into profit, but every time this has happened in the past we drop back to 50p before very long. Will we hold on this time? The increase accounted for around £8,750 of the overall rise this week.

JLP:Jubilee Metals is climbing relentlessly and is up by another 14% this week to go 208% up altogether and making £8,972 potential profit. All this is on no news, so when new deals are announced or production updates are issued, we could see further gains.

CAML:Central Asia Metals continues a dramatic recovery, climbing another 18% to go 47% up and making £4,844 potential profit.

FXPO:Ferrexpo also comes into the relentless climber category and is up 32% this week to go 87% up and making £882 potential profit.

Share of the Week is my new buy ITX:Itaconix, which after a 16% drop last week climbed 47% to go 31% into the black with £160 potential profit on my small holding. It feels like this company has hit an inflection point like OPTI:Optibiotix, in that their product is inside so many other products that profit is inevitable. Their production costs are a lot higher that OPTI though, so much more risk.

I needn't have done a special blog post last night - we've still blasted through the red line. What a stunning chart!

I was beginning to think I would never see the line peeking above the water

The ISA and share portfolios look like this after week 23 of year 6

			Weekly Change
Cash	£32.95		-£3.75
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£63,733.70	(1.1%)	+£5,780.73
Potential profits	£9,999.34		+£1,627.29
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£107.26	(3.1%)	-£5.62
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£338.49	(9.7%)	-£1.26
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Nice rise into the black, with OPTI:Optibiotix returning to paper profit by £1,027 and JLP:Jubilee Metals increasing potential profit by £600. Just a few weeks ago this still seemed like a long way away. How long will it last?

Only just across the red line, but a joy to behold.

Quite a bounce off the trend line from a few weeks ago.

The SIPP looks like this after week 267 overall and week 7 of year 6.

			Weekly Change
Cash	£4,809.68		+£4,523.24
Portfolio cost	£59,093.46		-£2,719.87
Portfolio sell value (bid price - commission)	£62,414.01	(5.6%)	+£5,602.16
Potential profits	£7,212.36		+£1,633.28
Yr 6 Dividends	£378.23		+£17.73
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£1,802.30
Yr 6 projected avg monthly profit	£1,558.64	(46.7%)	+£1,042.67
Total Dividends	£2,445.31		+£17.73
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£1,802.30
Average monthly cash profit	£315.24	(9.4%)	+£28.19
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+4%

There's a lot going on here!

I sold just under half my SBTX:SkinBioTherapeutics holding yesterday because it went past the point where it usually drops. When it climbed to 31p today I felt it had gone way past where it should be and sold the rest. That decision cost me £150 as the price continued up to 33.5p. I think that's crazy for a company that hasn't got revenues for some time yet, no matter how much I love them. I ended up making £1,802.30 profit and liberated £4,522 which I am determined to hold for when they drop back below 20p.

Knowing my luck they will soar to 100p now. It doesn't matter, I own them by proxy from the OPTI:Optibiotix stake. SBTX is the one share that I am willing to actively trade and risk not being in when they take off properly. Doing so has made me £5,345 profit so far. You could argue I'd lose more than that by not being invested when they re-rate, but it's a risk I'm prepared to take due to my OPTI holding.

There was a £17 dividend from POLR:Polar Capital Holdings this week, somewhat lost amongst everything else.

Potential profits went up despite cashing in SBTX, annual projected performance is crazy, but it expects the first 7 weeks to continue for the rest of the year. If I don't sell anything else for the next 45 weeks then I would end up with 6.3% for this year, which isn't bad. Overall performance was boosted to 9.4%, and now that's measured against injection amount it won't plummet when I re-invest my profits.

Spectacular.

The dark days of April seem a long way away.

The trading account looks like this after week 233 overall and week 25 of year 5

			Weekly Change
Cash	£758.32		+£517.47
Portfolio cost	£1,855.69		-£511.72
Portfolio sell value (bid price - commission)	£1,523.19	(-17.9%)	+£59.32
Potential profits	£40.39		+£40.39
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£65.74
Yr 5 projected avg monthly profit	£111.60	(72.2%)	+£7.22
Dividends	£60.10		+£0
Profit from sales	£918.02		+£65.74
Average monthly cash profit	£18.19	(11.8%)	+£1.15
(Sold stocks profit + Dividends - Fees  / Months)

I sold my OPTI:Optibiotix trading shares for £65.74 (12.6%) profit. I have to admit I got scared because OPTI always drops after getting to break even in my main portfolio. I wasn't wrong as it did drop off a bit after I sold these. I also removed £60 to my bank account for my Madagascar holiday fund, which is why cash is only up just over £500.

Taking into account the sale, the rest f the portfolio gained £59 this week, and CAML:Central Asia Metals went into profit and I may be able to sell them next week. They are on quite a steady rise though, so I may hold a bit longer. Anything over £50 should be seen as a good profit in this account.

Long term performance is spectacular now, with 11.8% over four and a half years really good going. If I can keep up the year 5 performance of over £100 a month over the first six months I'll be very happy.

Note that the green line includes cash, so that will not go up next week when the red line bounces back by £500 when I re-invest the cash. The injection line is dropping beautifully as I take more out.

This is a much more meaningful chart as it sees through all the buying and selling and shows the difference between stock cost and value. Another small tick up despite profit taking, and the trend line is getting steeper upwards.

Here's my wish list:

1. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operation. Still nothing, but still the shares climb in value.
   
2. OPTI:Optibiotix Health to get back in profit. Yes! This one can now change to OPTI stays in profit. Some chance!.
3. CMCL:Caledonia Mining reverses the down trend and gets back into profit. A good 5% increase is moving this in the right direction.
   
4. The combined portfolios get back into the black. Yes!

I may abandon the wishes now, as I only have 2 left and they may struggle on for a long time.

One of the best weeks ever, and green all over my spreadsheet. If you add up potential profit and cash it comes to £22,853 which is wonderful. I feel nervous being out of SBTX:SkinBioTherapeutics, but I have a plan and I'm trying to stick to it without letting emotion get in the way. If SBTX does soar, then I should look at it as an opportunity to spend the cash on 4 new magic formula shares instead, as they are proving themselves to be pretty great. Also, if this happens then OPTI:Optibiotix will benefit and I'll be quids in anyway, so I shouldn't fret or wish SBTX drops back below 20p. Well, maybe just a little bit...